Companies: 10,795·Total market cap: $144.5T
Roivant Sciences Ltd.

Roivant Sciences Ltd.

ROIVNASDAQHealthcare● Active
$28.58
$-0.95(-3.22%)
Market Cap$20.6B
P/E Ratio—
52W High$32.793
52W Low$10.705
Shares OutstandingFinancialsRevenue

Roivant Sciences Ltd. (ROIV) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

ROIV · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
693.9M▼ -4.35% YoY Change
FY · as of Mar 31, 2026 · Reported in USD
vs 725.4M in FY 2025
Diluted Shares Outstanding
693.9M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
-4.35%
year-over-year
Float (Free Float)
516.2M
publicly tradable shares
71.8% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRdeclining
-0.9%
2023 → 2026
5-Year CAGRincreasing
+0.3%
2021 → 2026
10-Year CAGR—
—
—
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2026Latest
Diluted Shares: 693.9M
693.9M
-4.35%
FY 2025
Diluted Shares: 725.4M
725.4M
-7.39%
FY 2024
Diluted Shares: 831.0M
783.2M
+9.88%
FY 2023
Diluted Shares: 712.8M
712.8M
+6.43%
FY 2022
Diluted Shares: 669.8M
669.8M
-2.20%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs ROIV
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+260.6%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+250.0%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+156.6%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+123.4%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+31.1%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+29.4%
#7
Roivant Sciences Ltd.ROIV
Roivant Sciences Ltd.YOU
693.9M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Roivant Sciences Ltd. (ROIV) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of March 31, 2026, Roivant Sciences Ltd. reports 693.9M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Roivant Sciences Ltd.'s basic shares outstanding (693.9M) represents currently issued shares. Diluted shares outstanding (693.9M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Roivant Sciences Ltd.'s float is 516.2M (71.8% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float516.2M(71.8%)
Outstanding719.3M

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Roivant Sciences Ltd. (ROIV) shares outstanding history from 2020 to 2026. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Roivant Sciences Ltd. shares outstanding for the fiscal year ending March 31, 2026 were 693.9M, a 4.35% decline year-over-year. Roivant Sciences Ltd. FY 2026 shares outstanding were 693.9M, a -4.35% decline from FY 2025.

Roivant Sciences Ltd. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

ROIV shares outstanding · 4 questions

As of March 31, 2026, Roivant Sciences Ltd. (ROIV) has approximately 693.9M basic shares outstanding and 693.9M diluted shares outstanding. This represents a -4.35% year-over-year change from FY 2025 (725.4M). Roivant Sciences Ltd.'s declining share count is primarily driven by its share buyback program. For the complete historical data table, see the history table above.

ROIV shares outstandinghow many shares does ROIV haveROIV basic shares 2026ROIV diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Roivant Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08